17 results
8-K
EX-10.1
ADPT
Adaptive Biotechnologies Corp
12 Sep 22
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
8:45am
, reexamination proceeding, cancellation proceeding, injunction, lawsuit, declaratory judgment, administrative post-grant review proceeding, other
10-K
2019 FY
ADPT
Adaptive Biotechnologies Corp
26 Feb 20
Annual report
4:53pm
, could increase our insurance rates or prevent us from securing insurance coverage in the future. Additionally, any product liability lawsuit could … of any lawsuit or failure to obtain any of these licenses could prevent us from commercializing products or services, and the prohibition of sale of any
424B4
b1pj7lbj6
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
6qp4d7m 5hl
9 Jan 20
Draft registration statement
12:00am
424B4
tdbs adyws8nok
27 Jun 19
Prospectus supplement with pricing info
5:24pm
S-1
EX-10.2
f407shdxut 4u
30 May 19
IPO registration
5:20pm
S-1
hgw0a9
30 May 19
IPO registration
5:20pm
DRS/A
EX-10.2
161ahc4
8 May 19
Draft registration statement (amended)
12:00am
DRS/A
4lvl8v4 o0pp71iohvby
8 May 19
Draft registration statement (amended)
12:00am
DRS
49c733nt m3bqq
29 Mar 19
Draft registration statement
12:00am
- Prev
- 1
- Next